These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 27196316)
1. Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia. Cristofano A; Sapere N; La Marca G; Angiolillo A; Vitale M; Corbi G; Scapagnini G; Intrieri M; Russo C; Corso G; Di Costanzo A PLoS One; 2016; 11(5):e0155694. PubMed ID: 27196316 [TBL] [Abstract][Full Text] [Related]
2. Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study. Cao B; Wang D; Pan Z; Brietzke E; McIntyre RS; Musial N; Mansur RB; Subramanieapillai M; Zeng J; Huang N; Wang J Transl Psychiatry; 2019 Jan; 9(1):19. PubMed ID: 30655505 [TBL] [Abstract][Full Text] [Related]
3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
4. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related]
5. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results. de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709 [TBL] [Abstract][Full Text] [Related]
6. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Modrego PJ; Fayed N; Pina MA Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137 [TBL] [Abstract][Full Text] [Related]
7. Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women. Chondronikola M; Asghar R; Zhang X; Dillon EL; Durham WJ; Wu Z; Porter C; Camacho-Hughes M; Zhao Y; Brasier AR; Volpi E; Sheffield-Moore M; Abate N; Sidossis L; Tuvdendorj D Clin Nutr; 2017 Oct; 36(5):1310-1319. PubMed ID: 27624997 [TBL] [Abstract][Full Text] [Related]
9. Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes. Ulstein I; Bøhmer T J Alzheimers Dis; 2017; 55(2):717-725. PubMed ID: 27716664 [TBL] [Abstract][Full Text] [Related]
10. Acyl-Carnitine plasma levels and their association with metabolic syndrome in individuals with schizophrenia. Cao B; Chen Y; McIntyre RS; Yan L Psychiatry Res; 2020 Nov; 293():113458. PubMed ID: 32977055 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine and B vitamins in mild cognitive impairment and dementia. Quadri P; Fragiacomo C; Pezzati R; Zanda E; Tettamanti M; Lucca U Clin Chem Lab Med; 2005; 43(10):1096-100. PubMed ID: 16197304 [TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia. Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN Curr Med Res Opin; 1990; 11(10):638-47. PubMed ID: 2178869 [TBL] [Abstract][Full Text] [Related]
14. Urinary Medium-Chained Acyl-Carnitines Sign High Caloric Intake whereas Short-Chained Acyl-Carnitines Sign High -Protein Diet within a High-Fat, Hypercaloric Diet in a Randomized Crossover Design Dietary Trial. Khodorova NV; Rietman A; Rutledge DN; Schwarz J; Piedcoq J; Pilard S; Siebelink E; Kok FJ; Tomé D; Mensink M; Azzout-Marniche D Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916877 [TBL] [Abstract][Full Text] [Related]
15. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children. Lv QQ; You C; Zou XB; Deng HZ Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069 [TBL] [Abstract][Full Text] [Related]
16. Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease. Kalaria RN; Harik SI Ann Neurol; 1992 Oct; 32(4):583-6. PubMed ID: 1456745 [TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry. González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972 [TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659 [TBL] [Abstract][Full Text] [Related]